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ABSTRACT
Objective: Despite guidelines and campaigns, general practitioners (GPs) continue to overpre-
scribe benzodiazepines (BZDs). New approaches to improve prescribing are needed. Using
behavior change techniques and tailoring interventions to user characteristics are vital to pro-
mote behavior change. This study evaluated the impact of a tailored e-learning module on fac-
tors known to determine BZD prescribing within GPs.
Design: A pretest-posttest study design with three self-report assessments concerning determi-
nants of BZD prescribing: at baseline, immediately after the module (short term) and six months
after completion (long term).
Setting: Flanders (Belgium)
Intervention: A tailored e-module that focuses on avoiding initial BZD prescriptions and using
psychological interventions as an alternative.
Subjects: 244 GPs
Main outcome measures: Assessed determinants include GPs’ attitudes concerning treatment
options, perceptions of the patient and self-efficacy beliefs. Readiness to adhere to prescribing
guidelines was evaluated through assessing motivation, self-efficacy and implementability of
non-pharmacological interventions.
Results: A significant and durable impact on determinants of BZD prescribing was observed.
GPs underwent desirable changes in attitudes, perceptions and self-efficacy beliefs and these
changes remained significant six months later.
Conclusion: Tailoring an e-intervention to target group characteristics appears to be successful
in promoting behavioral change in experienced GPs. Significant and lasting changes were
observed in determinants of prescribing BZDs.
KEY POINTS
 A tailored e-intervention resulted in significant and long term changes in previously iden-
tified determinants of prescribing BZDs. The e-module resulted in a positive impact on
GPs’ readiness to adhere to BZD prescribing guidance and the way they experience psy-
chosocial consultations. Tailoring an e-intervention to target group characteristics appears
to be successful in promoting behavioral change in experienced GPs.
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Benzodiazepines (BZDs) are commonly used
psychotropic drugs for treating conditions such as
insomnia and anxiety in primary care, although their
long-term use is associated with considerable adverse
effects [1–3]. Despite guidance advocating use of non--
pharmacological, psychological treatments first-line (1),
and restricting BZDs to only short-term use if needed
(2), numerous studies have shown that BZDs are still
overprescribed and commonly used long-term [4–6].
General Practitioners (GPs) regard BZD prescribing
as one of the most complex, demanding and uncom-
fortable tasks in their clinical work [7] but they continue
to prescribe these drugs frequently and many
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prescriptions are even issued without the GP seeing the
patient [8]. Reviews identify a variety of reasons for
inconsistent BZD prescribing in primary care [9]. The
main concern for GPs is to help the patient: GPs try to
manage the tension between minimizing prescribing and
their responsibility to help ‘deserving’ patients [7,10].
Sirdifield et al. [9] developed an explanatory model
of processes underlying current prescribing practices
of BZDs in primary care. This model can be used to
support and evaluate interventions to improve adher-
ence to BZD prescribing guidance. The model empha-
sizes that prescribing BZDs is a behavioral outcome
determined by several factors. Interventions should
therefore not merely focus on acquiring knowledge
about BZDs or on non-pharmacological alternatives
but should also address other determinants contribu-
ting to inconsistent prescribing practices. Thus, train-
ing programs should also focus on ambivalent
attitudes and perceptions, as they are important deter-
minants of inconsistent prescribing strategies [11].
Educational interventions for Continuing Medical
Education (CME) typically focus on acquiring know-
ledge about correct prescribing [12] and are seldom
attuned to the psychological dynamics of GPs. Using
behavior change techniques is vital however, when
promoting behavior change [13,14].
Implementation science literature emphasizes the
importance of understanding key determinants and
a need for multifaceted and tailored strategies.
Interventions tailored to prospectively identified bar-
riers are more likely to improve professional practice
than dissemination of guidelines or educational mate-
rials alone [15].
Tailoring an intervention concerning BZD prescrib-
ing to target group characteristics was successful in
promoting behavioral change in inexperienced GPs
undertaking vocational training [16], but the impact of
a tailored intervention on experienced and practicing
GPs remains unknown.
This study evaluates the impact of a tailored e-
module on the readiness of experienced GPs to
adhere to BZD prescribing guidance: advocating the
use of non-pharmacological treatments first-line, and
using BZDs only short-term and if needed.
Material and methods
Participants and process
Over a five year period (2012–2016), Flemish GPs had
the opportunity to participate in a free e-module
developed by a multidisciplinary team at Ghent
University. The e-module was promoted on the
website of the Flemish professional organization for
GPs (Domus Medica). GPs who gave informed consent
for participating in the study were asked to complete
a self-report assessment when starting and ending the
e-learning module. Six months after completion, par-
ticipants received an email invitation to complete a
post-intervention questionnaire. Non-responders were
sent up to four reminders. All data were anonymized
before analysis.
Context
This study was conducted in Flanders (the Dutch-
speaking part of Belgium). Belgium has an accessible
health system, but mental health and mental health-
care indicators are alarming [17]. Relevant within the
context of BZD prescribing is that in Belgium there is
fee-for-service payment and there is no patient list
(with a free choice of GP). BZD consumption in
Belgium is very high: 13% of the adult population had
used BZD in the two weeks preceding a national
health interview survey. Among females aged 75þ,
use rises to 40% [18]. This despite the fact that in the
past decennium several campaigns have been organ-
ized by the Federal Government to address this issue.
Intervention
The intervention (Additional File) focused primarily on
avoiding initial BZD prescriptions and using psycho-
logical interventions [19–23] as an alternative. The
intervention was a web-based and tailored program: it
sought to address to GPs’ ambivalent attitudes and
perceptions, which are known to determine their pre-
scribing practices [9] and not merely focus on GPs
acquiring knowledge. The e-module drew on the the-
ory of Self-Determination (SDT [24], which provides
both theoretical grounds and practical guidelines to
create motivating learning environments [24–26].
According to SDT [24], the e-module aimed to fulfil
basic psychological needs for autonomy, competence,
and relatedness of participants.
Outcome measures
The intervention was evaluated for its impact on previ-
ously identified determinants and readiness to adhere
to prescribing guidelines [9]. Assessed determinants
included attitudes concerning treatment options, percep-
tions of the patient and self-efficacy beliefs (Table 1).
Readiness to adhere to prescribing guidelines was eval-
uated by assessing motivation, self-efficacy (Table 2) and
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implementability of non-pharmacological interventions
(Table 3) (Additional File).
Assessments
Three self-report assessments took place: one pre-
intervention (baseline) and two post-intervention
assessments: immediately after completing the mod-
ule (short-term) and more than six months after com-
pletion (long-term) (Additional file).
Analysis
Effects of the intervention were identified within a
pretest-posttest study design. Short-term effects were
identified using the assessment undertaken when par-
ticipants completed the module as posttest. An
assessment was sent six months after completing the
intervention to identify long-term effects. The impact
of the intervention on psychological determinants was
analyzed using the non-parametric Wilcoxon signed-
rank test. Effects on readiness to adhere to guidelines
was analyzed using the nonparametric McNemar




During a five-year period (2012–2016) 722 (out of
approximately 7500 registered) Flemish GPs used
the e-module and completed a baseline self-report
assessment. Of these, 51% (n¼ 371) also completed a
self-report assessment when completing the e-module.
Table 1. Impact on GPs’ Psychological Determinants of BZD prescribing (n¼ 244) at baseline, when ending the module (short
term) and six months later (long term).
Strongly disagree (%) Disagree (%) No opinion (%) Agree (%) Strongly agree (%) Wilcoxon Z p Value
GPs’ attitudes concerning treatment options, determining BZD prescribing
1. The advantages of sleep medication outweigh the disadvantages.
Baseline 28.4 47.7 17.3 6.6 0
Short term 45.2 38.2 10.8 3.3 2.5 4.055 <.001
Long term 42.2 38.4 11.4 5.9 2.1 2.853 .004
2. There are no non-drug alternatives for sleep problems that are as effective as drugs.
Baseline 19.3 45.1 19.7 13.5 2.5
Short term 36.3 42.1 11.3 7.9 2.5 4.390 .000
Long term 31.1 45.4 15.1 7.6 .8 4.487 .000
3. I don’t have time to treat sleep problems using non-drug therapies.
Baseline 17.3 45.7 20.2 16.5 .4
Short term 15.4 44.8 24.5 14.5 .8 .645 .519
Long term 18.9 42.4 21.4 15.1 2.1 .080 .937
4. The non-medication treatment of sleep problems is the business of other professionals.
Baseline 25.8 49.6 16 7 1.6
Short term 23.3 52.1 16.7 6.3 1.7 .068 .945
Long term 30.8 44.3 16.5 8.4 0 .585 .559
5. Non-drug treatment of sleep problems needs to be supported with medication.
Baseline 23.5 50.2 23 3.3 0
Short term 33.3 50.4 12.9 2.9 .4 3.301 .001
Long term 39.8 47.5 12.3 .4 0 6.212 <.001
GPs’ perception of the patient, determining BZD prescribing
6. If I do not prescribe medication to a patient with sleep problems, (s)he is dissatisfied.
Baseline 5.3 32.4 23 37.7 1.2
Short term 6.6 42.7 27 22.4 1.2 3.893 <.001
Long term 9.2 36.6 27.3 24.4 2.5 2.919 .004
7. It is difficult for a GP to motivate a patient with sleep problems to choose a non-medication. treatment.
Baseline 4.5 16.9 9.5 53.7 15.3
Short term .8 32.9 14.6 46.3 5.4 4.674 <.001
Long term 5.5 25.2 18.1 45 6.3 4.592 <.001
GPs’ self-efficacy beliefs, determining BZD prescribing
8. When I am not prescribing medication for sleep problems I feel like I am not empathic.
Baseline 33.6 41.4 11.5 13.1 .4
Short term 35.8 47.5 10.8 5.8 0 2.657 .008
Long term 43.7 40.3 10.1 4.2 1.7 3.180 .001
9. I have the expertise to use non-drug treatment for sleep problems.
Baseline 6.6 38.1 34 20.5 .8
Short term 2.1 12.1 29.2 53.8 2.9 8.990 <.001
Long term 3.4 13.1 26.6 51.1 5.9 7.851 <.001
10. I often feel overwhelmed when a patient presents with psychosocial problems.
Baseline 27.9 46.7 12.7 12.3 .4
Short term 25.3 52.7 13.3 8.3 .4 .935 .350
Long term 27.4 45.1 17.7 8.4 1.3 .266 .790
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Table 2. GPs’ readiness to adhere to prescribing guidelines (n¼ 244) at baseline, when ending the
intervention (short term) and more than six months later (long term).
Intention to change selected by (%) Mc Nemar v2 p Value
1. I intend to prescribe less sleep medication within the next weeks (<one month).
Baseline 12.7
Short term 34 32.513 <.001
Made efforts to change
2. I have tried in the past to prescribe less sleep medication
Baseline 46.3
Long term 59.8 27.534 <.001
Self-efficacy beliefs
3. I intend to prescribe less sleep medication but don’t know how.
Baseline 17.6
Short term 1.7 35.220 <.001
Long term .8 33.231 <.001
4. I am trying at the moment to prescribe less sleep medication but without success.
Baseline 29.1
Short term 14.5 22.667 <.001
Long term 7.1 36.125 <.001
5. I am trying at the moment to prescribe less sleep medication and have succeeded in doing so.
Baseline 18.4
Short term 46.1 51.247 <.001
Long term 56.9 72.640 <.001
Table 3. Implementability of 6 demonstrated alternative treatment strategies (n¼ 244)
Perceived meaningfulness and usefulness of treatment strategies when ending the module (short
term) and perceived usefulness and actual use more than six months later (long term).
Short term Long term
Meaningful (%) Useful (%) Useful (%) Used (%)
1. ICE model of communication
strongly disagree / never used 0 0 2.1 14.5
disagree 1.6 3.7 5
neutral. no opinion / rarely used 6.2 10.8 17.4 34.9
agree 42 50.6 49.2
strongly agree / frequently used 50.2 34.9 26.4 50.6
1. Sleep hygiene education
strongly disagree / never used 0 0 .4 3.3
disagree .8 .8 .8
neutral. no opinion / rarely used 2.5 2.5 5 28.9
agree 28.2 30 37.2
strongly agree / frequently used 68.5 66.7 56.6 67.8
2. Stress-vulnerability model
strongly disagree / never used .4 .8 .8 18.9
disagree 3.3 5 4.6
neutral. no opinion / rarely used 9.5 14.9 13.3 43.7
agree 48.1 43.6 44.6
strongly agree / frequently used 38.6 35.7 36.7 37.4
3. Sleep wake diary
strongly disagree / never used .4 1.2 5.4 35.7
disagree 2.1 3.7 7.9
neutral. no opinion / rarely used 6.6 19.9 24.5 53.5
agree 49.2 45.2 47.7
strongly agree / frequently used 41.7 29.9 14.5 10.8
4. Stimulus control therapy
strongly disagree / never used 0 .4 1.7 32.5
disagree 1.2 1.7 7.4
neutral. no opinion / rarely used 7.1 13.2 28.9 50
agree 46.9 43 40.1
strongly agree / frequently used 44.8 41.7 21.9 17.5
5. ABC model
strongly disagree / never used .4 1.2 2.9 47.1
disagree 5.4 10.7 14.2
neutral. no opinion / rarely used 10.7 25.2 26.7 43.8
agree 54.1 44.6 43.3
strongly agree / frequently used 29.3 18.2 12.9 7.1
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Most participants (83%) reported having spent more
than two hours on the e-module and most (75%)
chose to spread the e-learning over time (as sug-
gested), taking a median of 14 days.
244 GPs (34% of the initial 722 participants) also
completed the long-term follow-up assessment, with a
median of seven months between this assessment and
the baseline assessment. Only participants (n¼ 244)
who completed all three assessments were included in
further analysis.
Table 4 shows gender and years of experience of
the participants at all three assessments; only small
differences were observed between different groups.
Determinants of BZD prescribing at baseline
Baseline characteristics show that many participating
GPs (46.3%) had previously tried to prescribe less
sleep medication, but only 18.4% succeeded in doing
so (Table 2).
Consistent with these efforts, many participating
GPs showed several desirable attitudes and self-effi-
cacy beliefs at baseline (Table 1): for several items (1,
4, 5, 8, 10), more than 2/3 participants reported desir-
able attitudes and self-efficacy beliefs. Psychological
determinants of BZD prescribing are considered
‘desirable’ when participants indicate ‘helping’ atti-
tudes, perceptions or beliefs on the Likert scale. Not
having an opinion is therefore considered a ‘non-
desirable’ factor.
A significant number of participants reported atti-
tudes that were barriers to adherence to BZD prescrib-
ing guidance at baseline: 35.7% questioned whether
non-drug alternatives were as effective as medication
and 37% were not sure they had enough time to use
non-drug therapies (items 2, 3).
How our participants perceived sleepless patients
also appeared to be a barrier to adherence to pre-
scribing guidance. Few (37.7%) participants were con-
vinced that they could satisfy a patient without a drug
prescription (item 6). Furthermore, most participants
(69%) agreed that motivating patients to choose a
non-drug treatment was difficult (item 7). Concerning
self-efficacy, at baseline only 21.3% of the participating
GPs felt they had the expertise to use a non-drug
treatment (item 9).
Impact of the e-module on psychological
determinants
The assessments showed a desirable, significant and
durable impact of the intervention for many determi-
nants of BZD prescribing (Table 1). In this paragraph,
we focus on the long term impact of the module, but
the (analogous) short term results are listed in the
table as well.
First, the assessments showed enduring changes in
GPs’ attitudes concerning treatment options: several
months after the intervention, attitudes changed sig-
nificantly. Participants disagreed more strongly with
the statement that the advantages of BZDs outweigh
their disadvantages (Z¼2.853, p¼ .004) and they
judged more strongly that non-drug alternatives are
as effective as BZDs (Z¼4.487, p¼ .000). Participants
disagreed more strongly that non-drug treatments
need to be supported with medication (Z ¼ 6.212,
p< .001). Neither the idea of lacking time to use non-
drug interventions nor perceiving them as a business
of other professionals were changed significantly
(item 3–4).
In addition, the intervention significantly influenced
the way GPs perceived patients with sleep problems.
Months after the intervention and presumably after
seeing many patients, participants were less convinced
that it took a drug prescription to satisfy a patient
(Z¼2.919, p¼ .004) and they agreed less that it was
difficult to motivate patients to choose a non-drug
treatment (Z¼4.592, p< .001).
Further, participants reported a significantly stron-
ger sense of self-efficacy. Participants disagreed more
strongly that they had to show empathy by prescrib-
ing (Z ¼ 3.180, p ¼ .001) and felt more strongly that
they had the expertise to use non-pharmacological
interventions (Z¼7.851, p< .001). The number of
Table 4. Gender and years of experience of GPs who participated at the baseline assessment (n¼ 722), in survey 1 and 2
(n¼ 371) and of GPs who participated all 3 assessments (n¼ 244).
Baseline assessment (n¼ 722) Two assessments (n¼ 371) Three assessments (n¼ 244)
Male (%) Female (%) Total (%) Male (%) Female (%) Total (%) Male (%) Female (%) Total (%)
<10 years (%) 15.1 34.3 49.4 16.3 38.5 54.8 15.2 41.4 56.6
10–20 years (%) 4.2 12 16.2 2.9 10.2 13.1 1.6 10.7 12.3
20–30 years (%) 8.9 6.4 15.2 8 5.1 13.1 8.6 5.3 13.9
>30 years (%) 16.1 3 19.1 16 2.9 19 13.1 4.1 17.2
Total (%) 44.2 55.8 100 43.3 56.7 100 38.5 61.5 100
Only participants (n¼ 244) who completed all three assessments were included in further analysis (marked pale grey).
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GPs who felt they had such expertise almost tripled:
from 21.3% at baseline to 57% several months after
the intervention.
The module did not have an impact on feeling
overwhelmed when a patient presents with psycho-
social problems, but few participants (12.7%) reported
this barrier at baseline.
Impact of the e-module on readiness to adhere to
prescribing guidelines
The module showed significant and desirable effects
on participants’ readiness to change their prescribing
behavior (Table 2). Firstly, the intervention appeared
to have a significant and positive effect on partici-
pants’ intentions and efforts to change their prescrib-
ing practices: on completing the module the number
of participants intending to prescribe fewer BZDs
almost tripled.
More relevant however, was the significant and
enduring impact on participants’ self-efficacy beliefs.
The small number (17.6%) of GPs who reported not to
know how to meet their goal of prescribing fewer
BZDs reduced to almost zero in the longer term.
Furthermore, analyses showed a significant effect on
the number of participants reporting success in mini-
mizing BZD prescribing. When starting the module,
only 18.4% reported success, while several months
after completing the e-module, 56.9% reported suc-
cessfully minimizing BZD prescribing: this number
more than tripled.
At the time of ending the e-module, 95.8% of the
participants evaluated the intervention as ‘meaningful’
and months after the intervention more than 85%
stated that the module did change their prescrib-
ing practice.
Participants reported implementing several of the
demonstrated, non-pharmacological interventions
(Additional File) in their practice (Table 3): every
approach included in the e-module was used and con-
sidered practically useful by most participants. In par-
ticular, the ‘ICE model of communication’ (50.6%) and
the booklet on sleep hygiene education (67.8%) were
frequently used. ‘The ABC model’ (Activating events –
Beliefs – Consequences) [27] was the non-drug inter-
vention which was least often implemented, but was
nevertheless used by 50.9% of our GPs. The ‘stress-
vulnerability model’, ‘the sleep wake diary’ and the
booklet on stimulus control therapy were considered
practically useful by most, although opinions were div-
ided on these interventions.
Discussion
Principal findings
We documented a significant and lasting impact of a
tailored e-module on determinants of BZD prescribing
among practicing GPs: GPs underwent desirable
changes in previously identified attitudes, perceptions
and self-efficacy beliefs and these changes remained
significant six months later. Along similar lines, readi-
ness to adhere to prescribing guidelines was
enhanced and GPs reported experimenting with sev-
eral demonstrated, non-drug interventions within
these complex consultations.
Strengths and weaknesses
The intervention described is innovative in several
ways. It is a web-based and GP-tailored intervention
that is attuned to GPs’ ambivalent attitudes, percep-
tions, and self-efficacy beliefs. It focuses on avoiding
initial BZD prescriptions and using psychological treat-
ments as an alternative. Although the best way to
avoid BZD dependence is by not initiating these drugs
[7], few interventions focus on initial prescriptions.
Secondly, we demonstrate that a theoretical and psy-
chological understanding of underlying processes
helps to guide the development of effective
interventions.
Thirdly, our study highlights that e-learning can be
used effectively to attune to GPs and modify their atti-
tudes, perceptions and self-efficacy beliefs in the lon-
ger term.
Fourthly, we demonstrated educational interven-
tions targeting health professionals can be evaluated
by selecting relevant psychological determinants as
outcome measures. Thinking beyond decreased BZD
prescriptions, we were able to strengthen GP charac-
teristics that are likely to lead to better prescrib-
ing practices.
Our study has some important limitations as well.
Voluntary participation is unavoidable, but suggests a
sense of responsibility for BZD prescribing practice
among participants. Also, reasons for dropping out of
our study remain unknown. Thus a selection bias must
be taken into account, certainly since participants’ motiv-
ation for engaging in the intervention and assessments
was probably linked to the questioned determinants.
Another important limitation concerns the validity
and reliability of the assessments, which is a common
challenge when tailoring implementation strategies
[28]. No validated scales were used, rather items were
constructed to assess specific determinants of
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prescribing BZDs and readiness to adhere guidelines.
Therefore caution is required when interpreting the
observed changes.
Furthermore, we were not able to register the
impact of the e-module on rates of BZD prescribing.
Although operationalizing improvement in prescribing
by registering quantities of BZD prescriptions is ques-
tionable, measuring actual behavior (change) would
have been valuable. We documented the effectiveness
of the intervention through durable changes in several
psychological determinants of prescribing BZD. Since
people do not always do what they want to do or
think they do, it is inevitable that there is a gap
between psychological determinants, reported behav-
ior and actual behavior.
Comparison with existing literature
Changing the behavior of health professionals is chal-
lenging [14] and not to the least it remains a pain
point how to enhance adherence to mental health
clinical guidelines [29]. The field of implementation
science stresses that evidence based practice must be
complemented by evidence-based implementation.
Yet, many questions remain how to effectively trans-
late evidence into public health impact [28]. Reviews
continue to pinpoint implementation strategies often
fail to address key determinants and mechanisms of
change are seldom mentioned or tested when evaluat-
ing implementation strategies [28].
Concerning BZD prescribing, the tale is no different.
We found no literature on other tailored interventions
that specify and test mechanisms of change within
GPs’ BZD prescribing. The same e-intervention
appeared to be successful in promoting behavioral
change in inexperienced GPs undertaking vocational
training [16]. This study indicates it is meaningful in
experienced GPs as well.
The e-intervention succeeded in motivating experi-
enced GPs to actually implement several non-pharma-
cological interventions within their consultations. It is
peculiar that implementing these non-pharmacological
interventions did not highlight barriers such as lacking
time for non-drug interventions or perceiving these to
be the task of other professionals within GPs. This is
surprising, since these are barriers to adhering pre-
scribing guidelines often cited in literature [9].
Implications
Although many questions remain, it is encouraging
that an attuned e-intervention succeeded in changing
something within experienced GPs on the longer
term. Further research is needed to explore whether
this could help to resolve the deadlock concerning
BZD overprescription.
Since educational interventions that are obligatory
tend to achieve a larger reduction in BZD prescribing
[12], this could guide further research. Also, investigat-
ing which mechanisms of change (e.g. user character-
istics) are responsible for the observed effectiveness
could help to refine future interventions.
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